Bibliography
- Dhawan A , ChessemanP, Mieli-VerganiG: Approaches to acute liver failure in children.Pediatr. Transplant.8, 584–588(2004).
- Lee MW , SquiresRH, NybergSL, DooE, HoofnagleJH: Acute liver failure: summary of a workshop.Hepatology47(4), 1401–1415(2008).
- Fontana RJ : Acute liver failure including acetaminophen overdose.Med. Clin. North Am.92, 761–794(2008).
- Shah U , HabibZ, KlernmanRE: Liver failure attributable to hepatitis by viral infection in a developing country.Pediatrics105(2), 436–438(2000).
- Degertekin B , LokASF: Update on viral hepatitis: 2008.Curr. Opin. Gastroenterol.25, 180–185(2009).
- Rizzetto M : Hepatitis D: thirty year after.J. Hepatol.50(5), 1043–1050(2009).
- Roush SW , MurphyTV: Historical comparison of morbidity and mortality for vaccine preventable disease in United States.JAMA298, 2155–2163(2007).
- Perdigón- Villaseñor G , Fernández-CantónSB: Estadísticas vitales evolución reciente del comportamiento de las hepatitis virales en México, 1990–2007.Bol. Med. Hosp. Infant. Mex.66(2), 204–207(2009).
- Valdespino JL , Ruíz-GómezJ, Olaiz-FernándezGet al.: Seroepidemiología de la hepatitis A en México. Sensor de inequidad social e indicador de políticas de vacunación.Sal. Púb. Méx.49(S3), 377–385(2007).
- Ciocca M , Moreira- Silva SF, Alegria S et al.: Hepatitis A as an etiologic agent of acute liver failure in Latin America. Pediatr. Infect. Dis. J.26(8), 711–715(2007).
- Treem WR : Fulminant hepatic failure in children.J. Pediatr. Gastroenterol. Nutr.35(Suppl. 33), 38 (2002).
- O‘Grady JG , SchalmanSW, WilliamsR: Acute liver failure: redefining the syndromes.Lancet342, 273–275(1993).
- Baker A , AlonsoME, AwMM, CioccaM, PortaG, RosenthalP: Hepatic failure and liver transplant: working group report of pediatric gastroenterology, hepatology and nutrition.J. Pediatr. Gastroenterol. Nutr.39(Suppl. 2), S632–S639 (2004).
- Jones AE : Funciones Específicas del Hígado. Elsevier, Madrid, Spain, 405–416(2007).
- Cochran JB , LosekJD: Acute failure in children.Pediatr. Emerg. Care23(2), 129–135(2007).
- Teran JC , McCulloughAF: Nutrition in liver diseases. In: The Science and Practice Of Nutrition Support. Gottschlich MM (Ed.). Kendall/Hunt, IA, USA, 539 (2001).
- Sandoval A , MoranS, UribeM: Alteraciones nutricias en las enfermedades hepáticas In: Nutriología Médica. Casanova E (Ed.). Kaufer-Horwitz, Mexico, 398–368(2000).
- Bernal W : Intensive care support therapy.Liver Transpl.9(Suppl.), S15–S17 (2003).
- Stravitz RT : Critical management decisions in patient with acute liver failure.Chest134(5), 1092–1102(2008).
- Lucey MR , BrownKA, EversonGTet al.: Minimal criteria for placement adult on the liver transplant waiting list: a report a national conference organized by the American Society of transplant Physicians and the American Association for the Study of liver disease.Liver Transpl. Surg.3(6), 628–637(1997).
- Freeman RB , GishRG, HarperAet al.: Model for End-Stage Liver Disease (MELD) exception guidelines: results and recommendations from MELD exception study group and conference (MESSAGE) for the approval of patient who need liver transplantation with diseases not considered by standard MELD formula. MELD supplement.Liver Transpl.12(3), S128–S136 (2006).
- O‘Grady , Alexander GJM, Hyllar kM, Williams R: Early indicators of prognosis in fulminant hepatic failure. Gastroenterology97(2), 439–445(1989).
- Faraj W , DarF, BartlettA, Vilca Hernandez H, Marangoni G, Mukherji D: Auxiliary liver transplantation for acute liver failure in children. Ann. Surg.251(2), 351–356(2010).
- Lemberg A , FernandezMA: Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress.Ann. Hepatol.2, 95–102(2009).
- Arya R , GulatiS, DeopujariS: Management of hepatic ecephalopahy in children.Postgrad. Med. J.86, 34–41(2010).
- Pathikonda M , MunozSJ: Acute liver failure.Ann. Hepatol.9(1), 7–14(2010).
- Chu CJ , ChangCC, WangTF, LeeFY, ChangFY, ChenYC: Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of nitric oxide synthase isoforms.J. Gastroenterol. Hepatol.21(7), 1194–1199(2006).
- Albrecht J , DolinskaM: Glutamate as a pathogenic factor in hepatic encephalopathy.J. Neuroc. Res.61, 1–5(2001).
- Squires RH , ShneiderBL, BucuvalasJet al.: Acute liver failure in children: the first 348 patient in the pediatric acute liver failure study group.J. Pediatr.148(5), 652–658(2006).
- Squires RH : Acute liver failure in children.Semin. Liver Dis.28(2), 153–156(2008).
- Muñoz-Hernández O , Álvarez-MuñozMT, Dehesa-ViolanteM, Ángulo-GonzálezD, Solórzano-SantosF, Juárez-NavarroJA. Hepatitis viral. In: PAC-Infecto C-2, HEPATITIS. Muñoz-Hernández O (Ed.). Intersistemas, Mexico, 1–24(2005).
- Smilkestein MJ , Knnapp Gl, Kulig KW, Rumack BH: Efficacy of oral N-acetylcisteine in treatment of acetaminophen overdose. Analysis of the National Multicenter Study (1976–1985). N. Engl. J. Med.319(24), 1557–1562(1988).
- Harrison PM , WendonJA, GimsonAE, AlexanderGJ, WlliamsR: Improvement by acetylcisteine of hemodynamics and oxygen transport in fulminant hepatic failure.N. Engl. J. Med.324(26), 1852–1857(1991).
- Harrison PM , KeaysR, BrayGP, AlexanderGJ, WilliamsR: Improved outcome of paracetamol induced fulminant hepatic failure by late administration of acetylcisteine.Lancet355, 1572–1574(1990).
- Ben-Ari Z , VakinH, Tur-KaspaR: N-acetylcisteine in acute hepatic failure (non-paracetamol induced).Hepatol. Gastroenterol.47, 786–789(2000).
- Rank N , MichelC, HaertelCet al.: N-acetylcisteine increase liver blood flow and improves liver function in septic shock patients: results of a prospective, randomised double-blind study.Crit. Care Med.28, 3799–3807(2000).
- Liu Y , ZhangH, ZhangLet al.: Antioxidant N-acetylcisteine attenuates the acute liver injury caused by x-ray in mice.Eur. J. Pharmacol.575(1–3), 142–148(2007).
- Alipour M , OmriA, SmithMG, SuntresS: Prophylactic effect of liposomal N-acetylcisteine against LPS-induced liver injuries.J. Endotox. Res.13(5), 297–304(2007).
- Dart RC , RumackBH: Patient-tailored N-acetylcisteine admistration.Ann. Emerg. Med.50(3), 280–281(2007).
- Kortsalioudaki C , TaylorMR, CheesemanP, BansalS, Mieli-VerganiG, DhawanA: Safety and efficacy of N-acetilcysteine in children with non-acetaminophen-induced acute liver failure.Liver Transpl.14, 25–30(2008).
- Lee WM , HynanLS Rossaro L et al.: Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology137(3), 856–864(2009).
- Sotelo N , DurazoMA, GonzalezA, DhanakottiN: Early treatment with N-actetylcisteine in children with acute liver failure secondary to hepatitis A.Ann. Hepatol.8(4), 353–356(2009).
- Méndez-Sanchez N , Chávez-TapiaNC, EspinozaB, Herrera-GomarM, Zamora-ValdezD, UribeM: Acute liver failure and the molecular adsorbents recirculating system: early experience in a tertiary care hospital in Mexico city.Ann. Hepatol.3(4), 164–166(2004).
- Santantonio T , WiegrandJ, Tilman Gerlach J: Acute hepatitis C: current status and remaning challenges. J. Hepatol.49(4), 625–633(2008).
- FitzSimons D , HendrickxG, VostersA, Van Damme P: Hepatitis A and E: update on prevention and epidemiology. Vaccine28(9), 583–588(2010).
- Law M , MaruyamaT, LewisJ, GiangE, TarrAW, StamatakiZ: Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge.Nat. Med.14(1), 25–27(2008).